Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Bedford Laboratories, a division of Ben Venue Laboratories, has launched the sumatriptan succinate injection. This product is AP rated and is equivalent to Imitrex by GlaxoSmithKline.
Subscribe to our email newsletter
Sumatriptan is a vascular headache suppressant indicated for the acute treatment of migraine attacks with or without aura and the acute treatment of cluster headache episodes. Sumatriptan succinate injection is not for use in the management of hemiplegic or basilar migraine.
Bedford Laboratories will supply Sumatriptan succinate injection as a sterile aqueous solution in a 6mg (base)/0.5ml single-dose vial packaged in cartons containing 10 vials.